Perioperative intravenous lidocaine use in children
Pediatric Anesthesia · 2023-05 · 33 (5) · 336-346
DOI: 10.1111/pan.14608 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Anesthesia, online erschienen am 04.12.2022. Verfasst von Chloe Heath und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia and Pain Medicine, Perth Children's Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Lidocaine, Anesthetics, Local. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Perioperative pain management impacts patient morbidity, quality of life, and hospitalization cost. In children, it impacts not only the child, but the whole family. Adjuncts for improved perioperative analgesia continue to be sought to minimize adverse side effects associated with opioids and for those in whom regional or neuraxial anesthesia is not suitable. The use of ketamine and alpha agonists may be useful in these settings but have noted adverse effects including hallucinations, hemodynamic instability, and excessive sedation. One alternative is intravenous lidocaine. Despite its off‐label use, intravenous lidocaine has demonstrated anti‐neuropathic, anti‐hyperalgesic, and anti‐inflammatory actions and is an emerging technique. Multiple studies in adults have demonstrated beneficial effects of perioperative intravenous lidocaine including improved perioperative analgesia with reduced postoperative opioid use, improved gastrointestinal function, earlier mobilization, and reduction in hospital length of stay. Despite the limited pediatric literature, some of these findings have been replicated. Large‐scale trials providing evidence for the pediatric pharmacokinetics and high‐quality safety data with respect to intravenous lidocaine are still however lacking. To date, dose ranges studied in the pediatric population have not been associated with serious side effects and current data suggests perioperative intravenous lidocaine in a subgroup of pediatric surgical patients seems well‐tolerated and beneficial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesia and Pain Medicine, Perth Children's Hospital, Perth, Western Australia, Australia.
- Perioperative Medicine Team, Telethon Kids Institute, Perth, Western Australia, Australia.
- Department of Anaesthesia, Joondalup Health Campus, Joondalup, WA, Australia.
- Division of Emergency Medicine, Anaesthesia and Pain Medicine, Medical School, The University of Western Australia, Perth, Western Australia, Australia.
ORCID-Profile: Chloe Heath, Justin Hii, Britta S von Ungern-Sternberg, David Sommerfield
Zitieren
APA
Heath, C., Hii, J., Thalayasingam, P., von Ungern-Sternberg, B. S., & Sommerfield, D. (2023). Perioperative intravenous lidocaine use in children. Pediatric Anesthesia, 33(5), 336-346. https://doi.org/10.1111/pan.14608
Vancouver
Heath C, Hii J, Thalayasingam P, von Ungern-Sternberg BS, Sommerfield D. Perioperative intravenous lidocaine use in children. Pediatric Anesthesia. 2023;33(5):336-346. doi:10.1111/pan.14608
BibTeX
@article{Heath2023,
author = {Heath, Chloe and Hii, Justin and Thalayasingam, Priya and von Ungern-Sternberg, Britta S and Sommerfield, David},
title = {Perioperative intravenous lidocaine use in children},
journal = {Pediatric Anesthesia},
year = {2023},
volume = {33},
number = {5},
pages = {336--346},
doi = {10.1111/pan.14608}
}
EUVIMED